Expression of Met protein in thyroid tumours

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 266-270

  Ruco, Luigi P ^a   Ranalli, Teresa ^a   Marzullo, Antonella ^a   Bianco, Paolo ^b   Prat, Maria ^c   Comoglio, Paolo M ^c   Baroni, Carlo D ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Hepatocyte growth factor (HGF) receptor; Met protein; Scatter factor (SF) receptor; Thyroid tumours

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE C MET; PRIORITY JOURNAL; THYROID TUMOR;

ADENOCARCINOMA; ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0029844369     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q     Document Type: Article

References (34)

1. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989; 339: 155-156.
2. Gonzatti-Haces M, Seth A, Park M, Copeland T, Oroszlan S, Vande Woude GF. Characterization of the trp-met oncogene p65 and the met protooncogene p140 protein-tyrosine kinases. Biochemistry 1988; 85: 21-25.
3. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM. Biosynthesis of the protein encoded by the c-MET proto-oncogene. Oncogene 1989; 4: 1383-1388.
4. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
5. Naldini L, Vigna E, Narsimhan R, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 1991; 6: 501-504.
6. Gherardi E, Soker M. Hepatocytes and scatter factor. Nature 1990; 346: 228.
7. Naldini L, Weidner KM, Vigna E, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867-2878.
8. Prat M, Narsimhan R, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-328.
9. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991; 6: 1997-2003.
10. Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173: 42-47.
11. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor, hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223-235.
12. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signalling and transformation by the hepatocyte growth factor/ scatter factor receptor family. Cell 1994; 77: 261-271.
13. Cooper CS, Park M, Blair DG, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984; 311: 29-33.
14. Park M, Dean M, Cooper CS, et al. Mechanism of met oncogene activation. Cell 1986; 45: 895-904.
15. Soman NR, Correa P, Ruiz BA, Wogan G. The TPR-Met oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 1991; 88: 4892-4896.
16. Di Renzo MF, Olivero M, Ferro S, et al. Overexpression of the c-met/hgf receptor gene in human thyroid carcinomas. Oncogene 1992; 7: 2549-2553.
17. Di Renzo MF, Olivero M, Katsaros D, et al. Overexpression of the met-HGF receptor in ovarian cancer. Int J Cancer 1994; 58: 658-662.
18. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995; 55: 1129-1138.
19. Rosai J, Carcangiu ML, De Lellis LA. Atlas of Tumor Pathology. Tumors of the Thyroid Gland. Washington, DC: Armed Forces Institute of Pathology, 1992.
20. Prat M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio PM. C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol Cell Biol 1991; 11: 5954-5962.
21. Ponzetto C, Giordano S, Peverali F, et al. c-MET is amplified but not maturated in a cell line with an activated met tyrosine kinase. Oncogene 1991; 6: 553-559.
22. Wright PA, Lemoine NR, Mayall ES, et al. Papillary and follicular carcinoma show a different pattern of ras oncogene mutation. Br J Cancer 1989; 60: 576-577.
23. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 1990; 60: 557-563.
24. Hofstra RMW, Landsvater RM, Ceccherini I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367: 375-376.
25. Fagin JA, Matsuo K, Karmakar A, Chen DL. Tang S-H, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993; 91: 179-184.
26. Crepaldi T, Pollack AL, Prat M, Zborek A, Mostov K, Comoglio PM. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J Cell Biol 1994; 125: 313-320.
27. Suzuki K, Hayashi N, Yamada Y, et al. Expression of the c-met protooncogene in human hepatocellular carcinoma. Hepatology 1994; 20: 1231-1236.
28. Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplification of the met/hgf receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-154.
29. Grigioni WF, Fiorentino M, D'Errico A, et al. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology 1995; 21: 1543-1546.
30. Shimizu T, Usuda N, Yamanda T, Sugenoya A, Futoshi I. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 1993; 71: 2807-2812.
31. Katoh R, Bray CE, Suzuki K, et al. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 1995; 26: 139-146.
32. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805-828.
33. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature 1987; 327: 239-242.
34. Dremier S, Taton M, Coulonval K, Nakamura T, Matsumoto K. Mitogenic, dedifferentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 1994; 135: 135-140.